TL
BIO icon

TrueWealth LLC’s Bio-Rad Laboratories Class A BIO Stock Holding History

TrueWealth LLC’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$7K Hold
15
– – ﹤0.01% 516
2020
Q1 		$5K Hold
15
– – ﹤0.01% 541
2019
Q4 		$6K Hold
15
– – ﹤0.01% 537
2019
Q3 		$5K Hold
15
– – ﹤0.01% 557
2019
Q2 		$5K Hold
15
– – ﹤0.01% 563
2019
Q1 		$5K Hold
15
– – ﹤0.01% 564
2018
Q4 		$3K Hold
15
– – ﹤0.01% 607
2018
Q3 		$5K Hold
15
– – ﹤0.01% 608
2018
Q2 		$4K Hold
15
– – ﹤0.01% 646
2018
Q1 		$4K Hold
15
– – ﹤0.01% 606
2017
Q4 		$4K Buy
+15
New +$3.63K ﹤0.01% 691

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

TrueWealth LLC's BIO Position: Q2 2020 in Review

TrueWealth LLC held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2020 at 15 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #516.

TrueWealth LLC first reported a position in BIO in Q4 2017 and has held it in 11 quarters since. 470 funds tracked by Wall St. Rank hold BIO as of Q2 2020.

  • TrueWealth LLC held 15 shares of Bio-Rad Laboratories Class A worth $7K as of Q2 2020.
  • TrueWealth LLC left its Bio-Rad Laboratories Class A share count unchanged in Q2 2020.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of TrueWealth LLC's portfolio in Q2 2020, its #516 holding.
  • TrueWealth LLC first reported a position in Bio-Rad Laboratories Class A in Q4 2017 and has held it in 11 quarters since.
  • 470 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2020.

Based on TrueWealth LLC's 13F filing for Q2 2020, filed 15 Jul 2020.